Skip to main content
. 2021 Apr;13(4):2339–2350. doi: 10.21037/jtd-20-1603

Figure 3.

Figure 3

Comparison of MPE progression-free survival and OS between CR patients and PR/failure patients after 1st cycle of DEB-BACE. MPE progression-free survival in CR and PR/failure patients after 1st cycle of DEB-BACE (A); OS in CR and PR/failure patients after 1st cycle of DEB-BACE (B). MPE, malignant pleural effusion; CR, complete remission; PR, partial remission; DEB-BACE, drug-eluting beads bronchial arterial chemoembolization.